IL-6 signalling pathways and the development of type 2 diabetes

No abstract is available for this paper.

• Publication year

  2018

• Venue

  InflammoPharmacology

• Publication date

  2018-03-05

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10787-018-0458-0PMID 29508109
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of IL-6 in host defence against infections: immunobiology and clinical implications

  2017cited by this paper
• Acute hyperglycemia impairs IL‐6 expression in humans

  2016cited by this paper
• The role of interleukin-6 signaling in nervous tissue.

  2016cited by this paper
• Interleukin-6: Biology, signaling and strategies of blockade.

  2015cited by this paper
• Blocking IL-6 trans-signaling prevents high-fat diet-induced adipose tissue macrophage recruitment but does not improve insulin resistance.

  2015cited by this paper
• IL-6 as a keystone cytokine in health and disease

  2015cited by this paper
• Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes.

  2014cited by this paper
• Faculty Opinions recommendation of Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin.

  2014cited by this paper
• Effects of IL-6 and IL-6 blockade on neutrophil function in vitro and in vivo.

  2014cited by this paper
• Interleukin-6 signaling promotes alternative macrophage activation to limit obesity-associated insulin resistance and endotoxemia

  2014cited by this paper
• Interleukin-6 Signaling Drives Fibrosis in Unresolved Inflammation

  2014cited by this paper
• A new era for the treatment of inflammatory autoimmune diseases by interleukin-6 blockade strategy.

  2014cited by this paper
• B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile

  2013cited by this paper
• Adipose Tissue in Obesity-Related Inflammation and Insulin Resistance: Cells, Cytokines, and Chemokines

  2013cited by this paper
• Obesity-associated low-grade inflammation in type 2 diabetes mellitus: causes and consequences.

  2013cited by this paper
• Therapeutic targeting of the interleukin-6 receptor.

  2012cited by this paper
• IL-6 Trans-Signaling via the Soluble IL-6 Receptor: Importance for the Pro-Inflammatory Activities of IL-6

  2012cited by this paper
• Transsignaling of Interleukin-6 Crucially Contributes to Atherosclerosis in Mice

  2012cited by this paper
• Hitting a complex target: an update on interleukin-6 trans-signalling

  2012cited by this paper
• B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies

  2011cited by this paper
• Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells

  2011cited by this paper
• Macrophage-mediated inflammation in metabolic disease

  2011cited by this paper
• Type 2 diabetes as an inflammatory disease

  2011cited by this paper
• Serum and Gene Expression Profile of Tumor Necrosis Factor-α and Interleukin-6 in Hypertensive Diabetic Patients: Effect of Amlodipine Administration

  2010cited by this paper
• Normalization of obesity-associated insulin resistance through immunotherapy

  2010cited by this paper
• Effects of Inhibition of Interleukin-6 Signalling on Insulin Sensitivity and Lipoprotein (A) Levels in Human Subjects with Rheumatoid Diseases

  2010cited by this paper
• Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance

  2010cited by this paper
• Improvement of HbA1c during treatment with humanised anti-interleukin 6 receptor antibody, tocilizumab

  2010cited by this paper
• Interleukin-6 signaling in liver-parenchymal cells suppresses hepatic inflammation and improves systemic insulin action.

  2010cited by this paper
• Free fatty acids induce a proinflammatory response in islets via the abundantly expressed interleukin-1 receptor I.

  2009cited by this paper
• CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity

  2009cited by this paper
• Deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice

  2009cited by this paper
• Normalization of Obesity-Associated Insulin Resistance through Immunotherapy: CD4+ T Cells Control Glucose Homeostasis

  2009cited by this paper
• Adipose tissue distribution is different in type 2 diabetes.

  2009cited by this paper
• Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters

  2009cited by this paper
• Peripheral Mononuclear Cell Resistin mRNA Expression Is Increased in Type 2 Diabetic Women

  2008cited by this paper
• Regulation of Interleukin-6-induced Hepatic Insulin Resistance by Mammalian Target of Rapamycin through the STAT3-SOCS3 Pathway*

  2008cited by this paper
• Muscle as an endocrine organ: focus on muscle-derived interleukin-6.

  2008cited by this paper
• Dual Role of Interleukin-6 in Regulating Insulin Sensitivity in Murine Skeletal Muscle

  2008cited by this paper
• Interleukin-6 regulates pancreatic α-cell mass expansion

  2008cited by this paper
• Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells.

  2007cited by this paper
• Interleukin-6 Directly Increases Glucose Metabolism in Resting Human Skeletal Muscle

  2007cited by this paper
• Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17–producing human T helper cells

  2007cited by this paper
• Point: Interleukin-6 does have a beneficial role in insulin sensitivity and glucose homeostasis.

  2007cited by this paper
• Interleukin-6 Impairs the Insulin Signaling Pathway, Promoting Production of Nitric Oxide in Human Umbilical Vein Endothelial Cells

  2007cited by this paper
• Increased Number of Islet-Associated Macrophages in Type 2 Diabetes

  2007cited by this paper
• Interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasis

  2007cited by this paper
• Direct Cross-talk of Interleukin-6 and Insulin Signal Transduction via Insulin Receptor Substrate-1 in Skeletal Muscle Cells*

  2006cited by this paper
• Updating interleukin-6 classic- and trans-signaling

  2006cited by this paper
• Signaling specificity of interleukin-6 action on glucose and lipid metabolism in skeletal muscle.

  2006cited by this paper
• Interleukin-6 Increases Insulin-Stimulated Glucose Disposal in Humans and Glucose Uptake and Fatty Acid Oxidation In Vitro via AMP-Activated Protein Kinase

  2006cited by this paper
• Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB

  2005cited by this paper
• Type 2 diabetes: principles of pathogenesis and therapy

  2005cited by this paper
• Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB.

  2005cited by this paper
• Short-term infusion of interleukin-6 does not induce insulin resistance in vivo or impair insulin signalling in rats

  2004cited by this paper
• Significant association of the interleukin-6 gene polymorphisms C-174G and A-598G with type 2 diabetes.

  2004cited by this paper
• Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo.

  2004cited by this paper
• Novel immunosuppressive properties of interleukin‐6 in dendritic cells: inhibition of NF‐κB binding activity and CCR7 expression

  2004cited by this paper
• Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone.

  2003influential reference
• IL-6 signal transduction and its physiological roles: the signal orchestration model.

  2003cited by this paper
• Cellular Cholesterol Depletion Triggers Shedding of the Human Interleukin-6 Receptor by ADAM10 and ADAM17 (TACE)*

  2003cited by this paper
• Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study.

  2003cited by this paper
• Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes.

  2003cited by this paper
• Interleukin-6 (IL-6) Induces Insulin Resistance in 3T3-L1 Adipocytes and Is, Like IL-8 and Tumor Necrosis Factor-α, Overexpressed in Human Fat Cells from Insulin-resistant Subjects*

  2003cited by this paper
• Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice.

  2003cited by this paper
• Interleukin-6 induces cellular insulin resistance in hepatocytes.

  2002cited by this paper
• Interleukin-6-deficient mice develop mature-onset obesity

  2002cited by this paper
• Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses.

  2001cited by this paper
• Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes.

  2000cited by this paper
• IL-6 switches the differentiation of monocytes from dendritic cells to macrophages

  2000cited by this paper
• Production of interleukin‐6 in contracting human skeletal muscles can account for the exercise‐induced increase in plasma interleukin‐6

  2000cited by this paper
• Novel path to activation of vascular smooth muscle cells: up-regulation of gp130 creates an autocrine activation loop by IL-6 and its soluble receptor.

  1999cited by this paper
• Circulating levels of interleukin-6, its soluble receptor and interleukin-6/interleukin-6 receptor complexes in patients with type 2 diabetes mellitus

  1999cited by this paper
• Dendritic cells

  1998cited by this paper
• A bioactive designer cytokine for human hematopoietic progenitor cell expansion

  1997cited by this paper
• Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment.

  1997cited by this paper
• Interleukin-6 enhances glucose transport in 3T3-L1 adipocytes.

  1996cited by this paper
• Interleukin‐6 suppression of neutrophil apoptosis is neutrophil concentration dependent

  1995cited by this paper
• Soluble receptors for cytokines and growth factors: generation and biological function.

  1994cited by this paper
• Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130.

  1993cited by this paper
• The induction by human interleukin-6 of apoptosis in the promonocytic cell line U937 and human neutrophils.

  1992cited by this paper
• Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor.

  1992cited by this paper
• Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130.

  1989cited by this paper
• B cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes.

  1988cited by this paper
• Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2).

  1985cited by this paper
• 0021-972X/04/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 89(11):5577–5582 Printed in U.S.A. Copyright © 2004 by The Endocrine Society doi: 10.1210/jc.2004-0603 Interleukin-6 Regulates Human Adipose Tissue Lipid Metabolism and Leptin Produc

  year unknowncited by this paper

• Role of NOX2 in the regulation of inflammatory and apoptotic pathways in congolese patients with type 2 diabetes in Brazzaville

  2026cites this paper
• Epigenome-wide association study of circulating interleukin-6 connects DNA methylation to immunometabolic and inflammatory health

  2026influential citation
• Akkermansia muciniphila Ameliorates Chronic Sleep Deprivation-Induced Glucose Intolerance and Inflammatory Cytokine Activation.

  2026cites this paper
• Inflammatory Markers Among African American Adolescents with Type 2 Diabetes Mellitus and Obesity: A Cross-Sectional Study

  2026cites this paper
• The Effect of Bloodletting Therapy on Lipid Metabolism and Glucose Control in Type 2 Diabetes: A Case Report

  2026cites this paper
• Biomarkers in Diabetic Foot

  2026cites this paper
• Unraveling the Systems Biology of Curcumin: A Mini-review of its Anti-diabetic Potential through Network Pharmacology.

  2025cites this paper
• Impact of antidiabetic medications on inflammatory markers and adiponectin levels: a cross-sectional study in Iraqi patients with type2 diabetes

  2025cites this paper
• Association of interleukin-6 serum levels with local tumor stage and lymph node metastasis of urothelial carcinoma.

  2025cites this paper
• Immune cell dysfunction: A critical player in development of diabetes complications.

  2025cites this paper
• Effect of Quercetin on inflammatory markers in diabetes mellitus: a systematic review and meta-analysis of animal studies

  2025cites this paper
• Genetic and molecular insights into diabetic foot ulcers: Unveiling biomarkers for precision medicine

  2025cites this paper
• Prediction of Hyperinflammatory Phenotypes in Critically Ill Patients via Routine Clinical Data and IL-6: Towards Personalized Anti-Inflammatory Therapy

  2025cites this paper
• Safety and efficacy of allogeneic umbilical cord-derived mesenchymal stem cell transplantation in type 2 diabetes: a pilot clinical trial.

  2025cites this paper
• The impact of comorbidities on the prognosis of patients with septic arthritis

  2025cites this paper
• Exploring the Intersection of Diabetes and Musculoskeletal Health

  2025cites this paper
• Emerging biomarkers in type 2 diabetes mellitus.

  2025cites this paper
• Sitagliptin phosphate ameliorates chronic inflammation in diabetes mellitus via modulating macrophage polarization

  2025cites this paper
• The Antidiabetic Activity of Wild-Growing and Cultivated Medicinal Plants Used in Romania for Diabetes Mellitus Management: A Phytochemical and Pharmacological Review

  2025cites this paper
• Ingesting Nuts Can Regulate Adipokines Expression in Individuals Living with Overweight and Obesity: A Narrative Review of What Is Known So Far

  2025cites this paper
• Association of peripheral inflammatory cytokines with motor and non-motor symptoms in patients with Parkinson’s disease and type 2 diabetes mellitus

  2025cites this paper
• CEBPA as a potential hub gene for cutaneous inflammation in type 2 diabetes mellitus.

  2025cites this paper
• Exploration of the mechanism of quercetin against GDM based on network pharmacology and molecular docking

  2025cites this paper
• Interleukin-6 Blockade Does Not Impair Exercise-Induced Glucose Uptake and Insulin Sensitivity in Rheumatoid Arthritis.

  2025cites this paper
• Muscle and liver insulin resistance are associated with distinct plasma protein profiles; data from the DiOGenes trial.

  2025cites this paper
• JAK and MEK Pathways as Therapeutic Targets for Saphenous Vein Smooth Muscle Cell Dysfunction in Type 2 Diabetes via Regulation of Mitochondrial Activity

  2025cites this paper
• Overcoming Curcumin's Limitations: Synthetic Derivatives in Diabetes and Cancer Management

  2025cites this paper
• Polysaccharides from Anemarrhena asphodeloides Bge. improve glucose and lipid metabolism in diabetic rats via the PPAR-γ/NF-κB pathway

  2025cites this paper
• Evaluation of IL-6 and IL-17A Levels in Diabetic Iraqi Patients Infected with COVID-19

  2025cites this paper
• Comparative Efficacy of Different Exercise Modes on Inflammatory Markers in Patients With Type 2 Diabetes Mellitus: A Systematic Review With Pairwise and Network Meta‐Analyses

  2025cites this paper
• Inflammasomes: novel therapeutic targets for metabolic syndrome?

  2025cites this paper
• Assessment of IL_6 and IL_34 Serum in Patients with Diabetic Foot Ulcers

  2025cites this paper
• Sleep duration and quality, physical activity and cardiometabolic multimorbidity: findings from the English Longitudinal study of Ageing

  2025cites this paper
• Association of the IL‐6R rs2228145 polymorphism with diabetic nephropathy: A case‐control study

  2025cites this paper
• Cardiometabolic Risk in Psoriatic Arthritis: A Hidden Burden of Inflammation and Metabolic Dysregulation

  2025cites this paper
• Prognosis Prediction by 18F-fluorodeoxyglucose Positron Emission Tomography Parameters in Patients Undergoing Chemoradiation Therapy for Esophageal Cancer.

  2025cites this paper
• The role of the transcription factor NF-kB in the pathogenesis of inflammation and carcinogenesis. Modulation capabilities

  2025cites this paper
• Interleukin-6 regulates human ODAM gene expression in gingival epithelial cells

  2025cites this paper
• The duplexity of insulin: The integrated bioinformatics analysis and machine learning identified key genes for type 2 diabetes

  2025cites this paper
• Skeletal muscle disorders as risk factors for type 2 diabetes.

  2025cites this paper
• Repurposing Antidiabetic Drugs for Gangrene: A Mendelian Randomization and Text Mining Study

  2025cites this paper
• Discovery of FLF-15 as a novel selective inhibitor of ADAM17 to prevent hepatocellular carcinoma metastasis

  2025cites this paper
• IL-6 and Olfactory Dysfunction: Focus on Changes, Effects, and Mechanisms

  2025cites this paper
• Decoding Health: Exploring Essential Biomarkers Linked to Metabolic Dysfunction-Associated Steatohepatitis and Type 2 Diabetes Mellitus

  2025cites this paper
• Anti‐Inflammatory Effect of 21α‐Methylmelianol In Vitro and In Vivo via NF‐κ B/STAT Signaling Pathway Modulation

  2025cites this paper
• Text Mining and Drug Discovery Analysis: A Comprehensive Approach to Investigate Diabetes-Induced Osteoporosis

  2024cites this paper
• Relationship of thyroid parameters with chronic inflammation in patients with euthyroid type 2 diabetes

  2024cites this paper
• Revisiting the markers interleukin-6 and glucagon-like peptide-1 for targeting low-grade inflammation in type 2 diabetes: a meta-analysis and our lab experience

  2024cites this paper
• Characteristics of elderly diabetes patients: focus on clinical manifestation, pathogenic mechanism, and the role of traditional Chinese medicine

  2024cites this paper
• Improvement of glucose metabolism disorder by wheat dietary fibre depended on the intake mode and regulated through TLRs/NF-κB/TNF pathway in db/db mice

  2024cites this paper
• Semaglutide Alleviates Ovary Inflammation via the AMPK/SIRT1/NF‑κB Signaling Pathway in Polycystic Ovary Syndrome Mice

  2024cites this paper
• A Serum Multi-Parametric Analysis Identifies an Early Innate Immune Signature Associated to Increased Vaccine-Specific Antibody Production and Seroconversion in Simultaneous COVID-19 mRNA and Cell-Based Quadrivalent Influenza Vaccination

  2024cites this paper
• Neutrophil-to-lymphocyte ratio in type 2 diabetes patients combined with Lower Extremity Peripheral Artery Disease

  2024cites this paper
• The role of PANDER and its interplay with IL-6 in the regulation of GLP-1 secretion

  2024cites this paper
• The Concentrations of Interleukin-6, Insulin, and Glucagon in the Context of Obesity and Type 2 Diabetes and Single Nucleotide Polymorphisms in IL6 and INS Genes

  2024cites this paper
• Metabolic regulation of the immune system in health and diseases: mechanisms and interventions

  2024cites this paper
• The effect of Helicobacter pylori-derived extracellular vesicles on glucose metabolism and induction of insulin resistance in HepG2 cells

  2024cites this paper
• Update on non-infectious uveitis treatment: anti-TNF-alpha and beyond

  2024cites this paper
• Neuroprotective Effects of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors (Gliflozins) on Diabetes-Induced Neurodegeneration and Neurotoxicity: A Graphical Review

  2024cites this paper
• Circulating small non‐coding RNAs are associated with the insulin‐resistant and obesity‐related type 2 diabetes clusters

  2024cites this paper
• Histone demethylase JARID1C/KDM5C regulates Th17 cells by increasing IL-6 expression in diabetic plasmacytoid dendritic cells

  2024cites this paper
• Kynurenine pathway in type 2 diabetes: Role of metformin

  2024cites this paper
• Enzymatic Fructosylation of Phenolic Compounds: A New Alternative for the Development of Antidiabetic Drugs

  2024cites this paper
• Inonotus obliquus aqueous extract inhibits intestinal inflammation and insulin metabolism defects in Drosophila

  2024cites this paper
• Interleukin-6 as a Director of Immunological Events and Tissue Regenerative Capacity in Hemodialyzed Diabetes Patients

  2024cites this paper
• Anti-diabetic potential of Chamaerops humilis L. aerial parts: phenolic compounds with α-amylase and α-glucosidase inhibitory activates in-vitro, in-vivo and in-silico studies

  2024cites this paper
• Metabolic and inflammatory perturbation of diabetes associated gut dysbiosis in people living with and without HIV infection

  2024cites this paper
• Exploratory risk prediction of type II diabetes with isolation forests and novel biomarkers

  2024cites this paper
• Comparative analyses of anti-inflammatory effects of Resveratrol, Pterostilbene and Curcumin: in-silico and in-vitro evidences

  2024cites this paper
• Investigating Interleukin-6 Levels in Type 2 Diabetes Mellitus Patients With and Without Diabetic Nephropathy

  2024cites this paper
• IL-6 mediates olfactory dysfunction in a mouse model of allergic rhinitis.

  2024cites this paper
• Impaired skeletal muscle regeneration in diabetes: From cellular and molecular mechanisms to novel treatments.

  2024cites this paper
• Anti-Inflammatory Activity of Peptides from Ruditapes philippinarum in Lipopolysaccharide-Induced RAW264.7 Cells and Mice

  2024cites this paper
• Cytotoxicity and anti-inflammatory properties of a GLP-1 receptor agonist in a model of human peripheral blood mononuclear cell culture

  2024cites this paper
• Aloe juvenna Brandham & S.Carter as α‐Amylase Inhibitor and Hypoglycaemic Agent with Anti‐inflammatory Properties for Diabetes Management

  2024cites this paper
• White blood cells and type 2 diabetes: A Mendelian randomization study

  2024cites this paper
• Discovery of 6‐Acylamino/Sulfonamido Benzoxazolone with IL‐6 Inhibitory Activity as Promising Therapeutic Agents for Ulcerative Colitis

  2024cites this paper
• Personalizing Nutrition Strategies: Bridging Research and Public Health

  2024cites this paper
• Preventing CXCL12 elevation helps to reduce acute exacerbation of COPD in individuals co-existing type-2 diabetes: A bioinformatics and clinical pharmacology study.

  2024cites this paper
• Mechanisms of Action of Potentilla discolor Bunge in Type 2 Diabetes Mellitus Based on Network Pharmacology and Experimental Verification in Drosophila

  2024cites this paper
• The Combined Effects of High-Intensity Interval Exercise Training and Dietary Supplementation on Reduction of Body Fat in Adults with Overweight and Obesity: A Systematic Review

  2024cites this paper
• NF‐κB pathway as a molecular target for curcumin in diabetes mellitus treatment: Focusing on oxidative stress and inflammation

  2024cites this paper
• Comparative Analysis of Biomarkers in Type 2 Diabetes Patients With and Without Comorbidities: Insights Into the Role of Hypertension and Cardiovascular Disease

  2024cites this paper
• Analysis of type 2 diabetes mellitus‐related genes by constructing the pathway‐based weighted network

  2024cites this paper
• Evaluation of the Relationship Between Salivary Adipokine Levels With Appetite and Anthropometric Indices in Patients With Type 2 Diabetes

  2024cites this paper
• The companion dog as a model for inflammaging: a cross-sectional pilot study

  2024cites this paper
• Chinese herb couple against diabetes: integrating network pharmacology and mechanism study

  2024cites this paper
• Effects of a Circuit Training Program on Myokine Levels in Insulin-Resistant Women: A Randomised Controlled Trial

  2024cites this paper
• IL-6 and diabetic kidney disease

  2024cites this paper
• Antioxidant activities of developed natural smoothies and their effects on blood glucose levels and expression of pro-inflammatory genes in streptozotocin-induced diabetic rats

  2024cites this paper
• The gut microbiota intervenes in glucose tolerance and inflammation by regulating the biosynthesis of taurodeoxycholic acid and carnosine

  2024cites this paper
• Changes in skeletal muscle in diabetes mellitus

  2024cites this paper
• Verifying The Association Between IL6 -174G/C Polymorphism in Type 2 Diabetes Mellitus

  2024cites this paper
• The Interplay Between Cytokines and MicroRNAs to Regulate Metabolic Disorders

  2024cites this paper
• Research Advances in Fusion Protein-Based Drugs for Diabetes Treatment

  2024cites this paper
• Investigating the Impact of IL6 on Insulin Secretion: Evidence from INS-1 Cells, Human Pancreatic Islets, and Serum Analysis

  2024cites this paper
• A Review of Animal Models for Studying Bone Health in Type-2 Diabetes Mellitus (T2DM) and Obesity

  2024cites this paper
• Effect of continuous positive airway pressure therapy on blood levels of IL-6, IL-10, IL-18, IL-1β, IL-4, and IL-17 in obstructive sleep apnoea adults: A systematic review, meta-analysis and trial sequential analysis.

  2024cites this paper
• Targeting Glucose Metabolism: A Novel Therapeutic Approach for Parkinson’s Disease

  2024cites this paper
• Integrated approach to reducing polypharmacy in older people: exploring the role of oxidative stress and antioxidant potential therapy

  2023cites this paper